Cancer Research UK Bets Big on Manchester With £6 Million Boost

Cancer Research UK (CRUK) has announced it will give its Manchester cancer institute more than £6 million in extra funding each year. That raises the institute's annual budget from £11 million to more than £17 million — a jump of over 50%. The money will help scientists in Manchester do more research, hire new staff, and compete with top cancer centers around the world.

The extra money is expected to create up to 100 new jobs at the CRUK Manchester Institute, which is part of the University of Manchester. Eight of those jobs will be for senior scientists who will work in areas like artificial intelligence (AI), computational biology, and immunology. Two more positions will be created at the nearby Christie NHS Foundation Trust, one of the UK's leading cancer hospitals.

AI is a big part of the plan. Magnus Rattray, a scientist at the University of Manchester, says the Christie hospital has huge amounts of patient data, and new AI tools can help researchers study that data in powerful new ways. He believes the technology will change cancer care 'all the way from prevention through to early detection, treatment in the clinic and designing the best possible treatment programmes.' That kind of progress could one day help doctors catch cancer sooner and choose better treatments for patients.

Immunology — the study of how the body's immune system fights disease — will also be a major focus. Samra Turajlić, the director of the Manchester Institute, says the UK has not fully developed this field compared to other countries. She believes Manchester has 'a very special opportunity' to build a strong center for cancer immunology by bringing together the institute's growing research team, the university's existing experts, and the Christie's work with real patients. The goal is for Manchester to become a world leader in using the immune system to fight cancer.

The funding boost also raises a bigger question about how cancer research money is spread across the UK. Right now, a lot of funding goes to universities in London, Oxford, and Cambridge — an area sometimes called the 'golden triangle.' The Manchester increase is large, but it is still much smaller than the £31.5 million that CRUK gave to the Institute of Cancer Research in London in 2024–25. This gap shows that regional research centers outside the golden triangle still receive far less support.

Some experts worry the UK is falling behind other countries in cancer research funding. In Germany, the German Cancer Research Center has a yearly budget of around €515 million, and France's Gustave Roussy cancer center has a budget of €592 million — both much larger than anything in the UK. A government report published in March 2025 warned that the UK has 'untapped potential for innovation-driven activity across the regions.' More investment in places like Manchester could help close that gap and bring world-class cancer research to more parts of the country.